NCT05413980 - Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

January 27, 2024

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions

Post Operative Endophthalmitis

Interventions

OTHER

Moxifloxacin hydrochloride ophthalmic solution

Prospective observational study. There is no treatment allocation. Patients prescribed with 0.5% Moxifloxacin hydrochloride ophthalmic solution during the perioperative period of ophthalmic surgery are eligible to enroll into this study.

Trial Locations (9)

110018

Novartis Investigative Site, Delhi

221010

Novartis Investigative Site, Varanasi

380016

Novartis Investigative Site, Ahmedabad

380052

Novartis Investigative Site, Ahmedabad

441108

Novartis Investigative Site, Nagpur

600045

Novartis Investigative Site, Chennai

682041

Novartis Investigative Site, Kochi

700073

Novartis Investigative Site, Kolkata

700106

Novartis Investigative Site, Kolkata